The Standard

Bridging the gaps: The struggle of managing sugar condition in Kenya

From delayed diagnosis to inconsistent access to essential medicines, these systemic shortcomings turn a manageable condition ...

Algorithm matches drugs to glioblastoma's diverse cell types, offering hope for individualized therapies

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...

Cracking prostate cancer's code: An enzyme's central role in controlling subtypes and improving therapeutic response

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...
MPR

Atacicept for IgA Nephropathy Granted FDA Priority Review

Atacicept is a recombinant fusion protein that binds to and inhibits the activity of BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand).
News-Medical.Net on MSN

Novel approach uncovers possible drugs based on specific cellular targets for treating glioblastoma

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...